Karooooo Ltd (KRO)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 106,132.00 |
|---|---|
| 52-week range | 72,051.00 – 112,995.00 |
| Return, 1 month / 3 months | −0.6% / +6.1% |
| Return, 1 year / 3 years | +32.5% / +125.1% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 46.5% |
| Worst drawdown (1 year) | -19.5% |
| Average daily value traded | 193.32M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Karooooo Ltd is a South African company that provides telematics and software services for managing vehicles and mobile workforces. Through its Cartrack business, it supplies vehicle tracking, fleet management and related subscription services that let commercial operators and smaller businesses monitor their vehicles and field staff. The company serves customers in many countries, with its operations rooted in South Africa, and its products combine vehicle hardware with cloud-based software for day-to-day fleet administration.
On this site Karooooo Ltd appears as a stock on the Johannesburg Exchange (South Africa), code KRO, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Karooooo Ltd (KRO) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 106,132.00 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 33 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.5% and over the last three months it rose 6.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.8% | ||
| From 52-week high | -5.6% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.1% | ||
| 6-month return | 26.4% | ||
| 12-month return, skipping the last month | 33.3% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.5% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 193.32M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −0.6% |
| 3 months | +6.1% |
| 6 months | +26.4% |
| 1 year | +32.5% |
| 3 years | +125.1% |
| 5 years | +114.2% |
Signals
| 50-day / 200-day average | 103,665.24 / 88,566.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5,196.81 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jun 2023 | ZAC 1,610.0870 |
| 31 Aug 2022 | ZAC 1,005.3001 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.